Mounjaro weight loss drops — the facts behind the name

The myth: "Mounjaro drops" are a thing you can buy online

It is easy to understand why this search happens. Social media is saturated with posts about weight loss injections, and somewhere along the way the word "drops" attached itself to Mounjaro's name. Sellers of unregulated supplements, and occasionally outright counterfeit products, have leaned into that confusion. If you've spent time searching and found listings that seem almost plausible, you're not being naive, the marketing is deliberately designed to blur the line.

The blunt fact is that no product called Mounjaro drops exists on the MHRA's register of authorised medicines, and our Mounjaro drops page explains in full why every listing you may have seen falls outside licensed medicine. Tirzepatide, the active molecule in Mounjaro, is not available in any licensed drop, sublingual, or oral liquid form for weight management in the UK. The MHRA has issued public warnings about fake and unauthorised weight-loss products sold online, noting that some counterfeit pens have contained wholly different substances, including insulin, which caused hospitalisations. Any listing offering Mounjaro or tirzepatide in drop form is, at best, an unlicensed supplement with no proven effect, and at worst something far more dangerous. You can report suspect sellers directly via the MHRA's Yellow Card scheme.

The short version: if it's sold as drops, it isn't Mounjaro.

Why tirzepatide cannot simply be swallowed or absorbed under the tongue

Tirzepatide is a large peptide molecule. Peptides taken by mouth are broken down by stomach acid and digestive enzymes before they reach the bloodstream, the same fate as the protein in a piece of chicken. That is precisely why legitimate GLP-1 and dual-agonist medicines are designed as injections: subcutaneous delivery gets the active compound where it needs to go.

Some people ask about the Wegovy tablet (oral semaglutide), which does work as a daily pill. That product uses a patented absorption enhancer called SNAC to survive the stomach environment, a sophisticated pharmaceutical formulation that took years to develop and received MHRA approval in June 2026. Tirzepatide has no equivalent approved oral formulation for weight management in the UK, and if you have come across products marketed as tirzepatide drops, those claims have no basis in licensed pharmacology. A product claiming to deliver the same effect as Mounjaro via drops is making a pharmacologically implausible promise.

Understanding this is genuinely useful if you're weighing your options. Our tirzepatide overview covers the mechanism in plain terms, including why the injection route produces the clinical results it does.

What the licensed Mounjaro pen actually involves

Mounjaro is a once-weekly subcutaneous injection administered via a pre-filled KwikPen. Each pen contains four weekly doses. Treatment starts at 2.5mg (a dose designed to let your body adjust, not to maximise weight loss from week one) and is titrated upward by the prescriber, typically in four-week steps, through six available strengths up to 15mg.

In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants using tirzepatide 15mg lost an average of around 20–21% of their body weight over 72 weeks. Those results came alongside a reduced-calorie diet and increased physical activity, the injection works with lifestyle changes, not instead of them. If you have seen searches around GLP-1 tirzepatide drops, that page sets out clearly why no such licensed product exists and what the approved alternative actually looks like. The NHS medicines page for tirzepatide gives a clear patient-level summary of how the medicine works and what to expect.

The injection itself is given into the abdomen, thigh, or upper arm, rotating the site each week. Most people find the process straightforward after the first attempt; the pen is designed to make it as simple as possible. If the idea of injecting feels like a barrier, it's worth raising that during a consultation, prescribers hear it regularly, and there are practical ways to make it easier.

For a broader look at how Mounjaro fits into weight management, the Mounjaro and weight loss page covers eligibility, evidence and realistic expectations in full.

The only safe route to tirzepatide in the UK

Mounjaro is a prescription-only medicine. That classification exists because the decision about whether it suits a specific person requires clinical judgement, a review of your BMI, health history, current medicines, and circumstances. A prescriber considers factors that no supplement label or online quiz can replicate.

The licensed eligibility criteria set by the MHRA cover adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. Meeting those numbers doesn't automatically mean treatment is appropriate, the prescriber's assessment is the deciding step.

Through a regulated private pharmacy registered with the GPhC, the process is more accessible than many people expect. At nume (sorry, at our pharmacy) a GPhC-registered Independent Prescriber personally reviews every consultation the same day. There are no algorithms making approval decisions. If you'd like to understand what private treatment costs and what a legitimate price includes, the Mounjaro price comparison page sets that out honestly.

When you're ready to find out whether tirzepatide is clinically suitable for you, check your eligibility with our prescribers, the consultation is free, with no obligation.